Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Obesity

Free Subscription Articles published in Metabolism Retrieve available abstracts of 122 articles: HTML format

Single Articles

May 2024
1. AVENDANO MS, Perdices-Lopez C, Guerrero-Ruiz Y, Ruiz-Pino F, et al
   The evolutionary conserved miR-137/325 tandem mediates obesity-induced hypogonadism and metabolic comorbidities by repressing hypothalamic kisspeptin.
   Metabolism. 2024 May 8:155932. doi: 10.1016/j.metabol.2024.155932.
   PubMed     Abstract available
   
   
   
2. NEDELCUT S, Axer S, Olbers T
   The risk and benefit of revisional vs. primary metabolic- bariatric surgery and drug therapy - A narrative review.
   Metabolism. 2024;154:155799.
   PubMed     Abstract available
   
   
   April 2024
3. ZELJKOVIC A, Vekic J, Stefanovic A
   Obesity and dyslipidemia in early life: Impact on cardiometabolic risk.
   Metabolism. 2024;156:155919.
   PubMed     Abstract available
   
   
   
4. AWAZAWA M, Matsushita M, Nomura I, Kobayashi N, et al
   Imeglimin improves systemic metabolism by targeting brown adipose tissue and gut microbiota in obese model mice.
   Metabolism. 2024;153:155796.
   PubMed     Abstract available
   
   
   
5. ROSENDO-SILVA D, Gomes PB, Rodrigues T, Viana S, et al
   Clinical and molecular profiling of human visceral adipose tissue reveals impairment of vascular architecture and remodeling as an early hallmark of dysfunction.
   Metabolism. 2024;153:155788.
   PubMed     Abstract available
   
   
   March 2024
6. PENDERGRAST LA, Ashcroft SP, Ehrlich AM, Treebak JT, et al
   Metabolic plasticity and obesity-associated changes in diurnal postexercise metabolism in mice.
   Metabolism. 2024 Mar 11:155834. doi: 10.1016/j.metabol.2024.155834.
   PubMed     Abstract available
   
   
   
7. MENG M, Cao Y, Qiu J, Shan G, et al
   Zinc finger protein ZNF638 regulates triglyceride metabolism via ANGPTL8 in an estrogen dependent manner.
   Metabolism. 2024;152:155784.
   PubMed     Abstract available
   
   
   
8. KOKKINOS A, Tsilingiris D, Simati S, Stefanakis K, et al
   Bariatric surgery, through beneficial effects on underlying mechanisms, improves cardiorenal and liver metabolic risk over an average of ten years of observation: A longitudinal and a case-control study.
   Metabolism. 2024;152:155773.
   PubMed     Abstract available
   
   
   
9. REGMI P, Young M, Minigo G, Milic N, et al
   Photoperiod and metabolic health: evidence, mechanism, and implications.
   Metabolism. 2024;152:155770.
   PubMed     Abstract available
   
   
   
10. LAVILLE M, Robert M, Segrestin B
    Barriers to metabolic surgery and how to address them.
    Metabolism. 2024;152:155764.
    PubMed     Abstract available
    
    
    February 2024
11. RACHELLE H, Malak G, Houry P, Marc H, et al
    Mortality risk in patients with obesity and COVID-19 infection: a systematic review and meta-analysis.
    Metabolism. 2024 Feb 13:155812. doi: 10.1016/j.metabol.2024.155812.
    PubMed     Abstract available
    
    
    
12. SARABHAI T, Kahl S, Gancheva S, Mastrototaro L, et al
    Loss of mitochondrial adaptation associates with deterioration of mitochondrial turnover and structure in metabolic dysfunction-associated steatotic liver disease.
    Metabolism. 2024;151:155762.
    PubMed     Abstract available
    
    
    
13. SAMARASINGHE SNS, Woods C, Miras AD
    Bariatric Surgery in Women with Polycystic Ovary Syndrome.
    Metabolism. 2024;151:155745.
    PubMed     Abstract available
    
    
    
14. TSILINGIRIS D, Kokkinos A
    Advances in obesity pharmacotherapy; learning from metabolic surgery and beyond.
    Metabolism. 2024;151:155741.
    PubMed     Abstract available
    
    
    
15. MURPHY E, Finucane FM
    Addressing uncertainty about the role of structured lifestyle modification for metabolic surgery patients.
    Metabolism. 2024;151:155739.
    PubMed     Abstract available
    
    
    
16. BAUZA-THORBRUGGE M, Vujicic M, Chanclon B, Palsdottir V, et al
    Adiponectin stimulates Sca1(+)CD34(-)-adipocyte precursor cells associated with hyperplastic expansion and beiging of brown and white adipose tissue.
    Metabolism. 2024;151:155716.
    PubMed     Abstract available
    
    
    January 2024
17. FUKUSHIMA T, Maetani T, Chubachi S, Tanabe N, et al
    Epicardial adipose tissue measured from analysis of adipose tissue area using chest CT imaging is the best potential predictor of COVID-19 severity.
    Metabolism. 2024;150:155715.
    PubMed     Abstract available
    
    
    
18. ZIQUBU K, Dludla PV, Mabhida SE, Jack BU, et al
    Brown adipose tissue-derived metabolites and their role in regulating metabolism.
    Metabolism. 2024;150:155709.
    PubMed     Abstract available
    
    
    October 2023
19. STEINBACH E, Masi D, Ribeiro A, Serradas P, et al
    Upper small intestine microbiome in obesity and related metabolic disorders: A new field of investigation.
    Metabolism. 2023 Oct 24:155712. doi: 10.1016/j.metabol.2023.155712.
    PubMed     Abstract available
    
    
    
20. KARAKASIS P, Patoulias D, Pamporis K, Stachteas P, et al
    Safety and efficacy of the new, oral, small-molecule, GLP-1 receptor agonists orforglipron and danuglipron for the treatment of type 2 diabetes and obesity: systematic review and meta-analysis of randomized controlled trials.
    Metabolism. 2023 Oct 16:155710. doi: 10.1016/j.metabol.2023.155710.
    PubMed     Abstract available
    
    
    
21. TSUKAMOTO S, Suzuki T, Wakui H, Uehara T, et al
    Angiotensin II type 1 receptor-associated protein in immune cells: a possible key factor in the pathogenesis of visceral obesity.
    Metabolism. 2023;149:155706.
    PubMed     Abstract available
    
    
    
22. ULLAH R, Shen Y, Zhou YD, Fu J, et al
    Perinatal metabolic inflammation in the hypothalamus impairs the development of homeostatic feeding circuitry.
    Metabolism. 2023;147:155677.
    PubMed     Abstract available
    
    
    September 2023
23. KOKKORAKIS M, Katsarou A, Katsiki N, Mantzoros CS, et al
    Milestones in the journey towards addressing obesity; Past trials and triumphs, recent breakthroughs, and an exciting future in the era of emerging effective medical therapies and integration of effective medical therapies with metabolic surgery.
    Metabolism. 2023;148:155689.
    PubMed     Abstract available
    
    
    
24. CHEN W, Cui W, Wu J, Zheng W, et al
    Blocking IL-6 signaling improves glucose tolerance via SLC39A5-mediated suppression of glucagon secretion.
    Metabolism. 2023;146:155641.
    PubMed     Abstract available
    
    
    August 2023
25. POLYZOS SA, Vachliotis ID, Mantzoros CS
    Sarcopenia, sarcopenic obesity and nonalcoholic fatty liver disease.
    Metabolism. 2023 Aug 4:155676. doi: 10.1016/j.metabol.2023.155676.
    PubMed     Abstract available
    
    
    
26. HOFFMANN A, Meir AY, Hagemann T, Czechowski P, et al
    A polyphenol-rich green Mediterranean diet enhances epigenetic regulatory potential: the DIRECT PLUS randomized controlled trial.
    Metabolism. 2023;145:155594.
    PubMed     Abstract available
    
    
    
27. PARK SH, Helsley RN, Fadhul T, Willoughby JLS, et al
    Fructose induced KHK-C can increase ER stress independent of its effect on lipogenesis to drive liver disease in diet-induced and genetic models of NAFLD.
    Metabolism. 2023;145:155591.
    PubMed     Abstract available
    
    
    July 2023
28. FERNANDEZ-SAEZ EM, Losarcos M, Becerril S, Valenti V, et al
    Uroguanylin prevents hepatic steatosis, mitochondrial dysfunction and fibrosis in obesity-associated NAFLD.
    Metabolism. 2023 Jul 28:155663. doi: 10.1016/j.metabol.2023.155663.
    PubMed     Abstract available
    
    
    
29. MUTURI HT, Ghadieh HE, Abdolahipour R, Stankus HL, et al
    Loss of CEACAM1 in endothelial cells causes hepatic fibrosis.
    Metabolism. 2023;144:155562.
    PubMed     Abstract available
    
    
    June 2023
30. KOSCHKER AC, Warrings B, Morbach C, Seyfried F, et al
    Effect of bariatric surgery on cardio-psycho-metabolic outcomes in severe obesity: A randomized controlled trial.
    Metabolism. 2023 Jun 30:155655. doi: 10.1016/j.metabol.2023.155655.
    PubMed     Abstract available
    
    
    
31. JUNG EJ, Sung KW, Bae TH, Kim HY, et al
    The N-degron pathway mediates lipophagy: The chemical modulation of lipophagy in obesity and NAFLD.
    Metabolism. 2023 Jun 27:155644. doi: 10.1016/j.metabol.2023.155644.
    PubMed     Abstract available
    
    
    
32. AXELROD CL, Dantas WS, Kirwan JP
    Sarcopenic obesity: emerging mechanisms and therapeutic potential.
    Metabolism. 2023 Jun 26:155639. doi: 10.1016/j.metabol.2023.155639.
    PubMed     Abstract available
    
    
    
33. WEI F, Gu Y, He L, Kapoor A, et al
    HSD17B6 delays type 2 diabetes development via inhibiting SREBP activation.
    Metabolism. 2023;145:155631.
    PubMed     Abstract available
    
    
    
34. BOUTARI C, Hill MA, Procaccini C, Matarese G, et al
    The key role of inflammation in the pathogenesis and management of obesity and CVD.
    Metabolism. 2023 Jun 9:155627. doi: 10.1016/j.metabol.2023.155627.
    PubMed    
    
    
    
35. OH J, Park C, Kim S, Kim M, et al
    High levels of intracellular endotrophin in adipocytes mediate COPII vesicle supplies to autophagosome to impair autophagic flux and contribute to systemic insulin resistance in obesity.
    Metabolism. 2023 Jun 9:155629. doi: 10.1016/j.metabol.2023.155629.
    PubMed     Abstract available
    
    
    
36. DE OLIVEIRA MC, Silveira ALM, de Oliveira ACC, Lana JP, et al
    Eosinophils protect from metabolic alterations triggered by obesity.
    Metabolism. 2023 Jun 7:155613. doi: 10.1016/j.metabol.2023.155613.
    PubMed     Abstract available
    
    
    
37. LIU B, Zhong Y, Huang D, Yang L, et al
    LncRNA Nron deficiency protects mice from diet-induced adiposity and hepatic steatosis.
    Metabolism. 2023 Jun 3:155609. doi: 10.1016/j.metabol.2023.155609.
    PubMed     Abstract available
    
    
    
38. WANG H, Xiong Q, He G, Tang J, et al
    Hepatic IDH2 regulates glycolysis and gluconeogenesis.
    Metabolism. 2023;143:155559.
    PubMed     Abstract available
    
    
    
39. BARAZZONI R, Cederholm T, Zanetti M, Gortan Cappellari G, et al
    Defining and diagnosing sarcopenia: Is the glass now half full?
    Metabolism. 2023;143:155558.
    PubMed     Abstract available
    
    
    
40. BRETHVAD AO, Zakariassen HL, Holt J, Lundgren JR, et al
    Increased meal-induced neurotensin response predicts successful maintenance of weight loss - Data from a randomized controlled trial.
    Metabolism. 2023;143:155534.
    PubMed     Abstract available
    
    
    May 2023
41. CAPPELLARI GG, Semolic A, Zanetti M, Vinci P, et al
    Sarcopenic obesity in free-living older adults detected by the ESPEN-EASO consensus diagnostic algorithm: Validation in an Italian cohort and predictive value of insulin resistance and altered plasma ghrelin profile.
    Metabolism. 2023 May 26:155595. doi: 10.1016/j.metabol.2023.155595.
    PubMed     Abstract available
    
    
    
42. JAVAID HMA, Ko E, Joo EJ, Kwon SH, et al
    TNFalpha-induced NLRP3 inflammasome mediates adipocyte dysfunction and activates macrophages through adipocyte-derived lipocalin 2.
    Metabolism. 2023;142:155527.
    PubMed     Abstract available
    
    
    April 2023
43. PARK MJ, Choi KM
    Interplay of skeletal muscle and adipose tissue: sarcopenic obesity.
    Metabolism. 2023 Apr 29:155577. doi: 10.1016/j.metabol.2023.155577.
    PubMed     Abstract available
    
    
    
44. GUO X, Hu J, He G, Chen J, et al
    Loss of APOO (MIC26) aggravates obesity-related whitening of brown adipose tissue via PPARalpha-mediated functional interplay between mitochondria and peroxisomes.
    Metabolism. 2023 Apr 21:155564. doi: 10.1016/j.metabol.2023.155564.
    PubMed     Abstract available
    
    
    
45. CHONG B, Kong G, Shankar K, Chew HSJ, et al
    The global syndemic of metabolic diseases in the young adult population: A consortium of trends and projections from the Global Burden of Disease 2000-2019.
    Metabolism. 2023;141:155402.
    PubMed     Abstract available
    
    
    
46. REBELOS E, Mari A, Oikonen V, Iida H, et al
    Evaluation of renal glucose uptake with [(18)F]FDG-PET: Methodological advancements and metabolic outcomes.
    Metabolism. 2023;141:155382.
    PubMed     Abstract available
    
    
    March 2023
47. PAPADOPOULOS G, Legaki AI, Georgila K, Vorkas P, et al
    Integrated omics analysis for characterization of the contribution of high fructose corn syrup to non-alcoholic fatty liver disease in obesity.
    Metabolism. 2023 Mar 28:155552. doi: 10.1016/j.metabol.2023.155552.
    PubMed     Abstract available
    
    
    
48. BIANZANO S, Henrich A, Herich L, Kalsch B, et al
    Efficacy and safety of the ghrelin-O-acyltransferase inhibitor BI 1356225 in overweight/obesity: Data from two Phase I, randomised, placebo-controlled studies.
    Metabolism. 2023 Mar 21:155550. doi: 10.1016/j.metabol.2023.155550.
    PubMed     Abstract available
    
    
    
49. XU H, Yu W, Sun M, Bi Y, et al
    Syntaxin17 contributes to obesity cardiomyopathy through promoting mitochondrial Ca(2+) overload in a Parkin-MCUb-dependent manner.
    Metabolism. 2023 Mar 20:155551. doi: 10.1016/j.metabol.2023.155551.
    PubMed     Abstract available
    
    
    
50. LUO X, Li Z, Chen L, Zhang X, et al
    Monocarboxylate transporter 1 in the liver modulates high-fat diet-induced obesity and hepatic steatosis in mice.
    Metabolism. 2023 Mar 16:155537. doi: 10.1016/j.metabol.2023.155537.
    PubMed     Abstract available
    
    
    
51. MARLENE C, Christos MS
    Advances in physiology, design and development of novel medications changing the landscape of obesity pharmacotherapy.
    Metabolism. 2023 Mar 2:155531. doi: 10.1016/j.metabol.2023.155531.
    PubMed    
    
    
    February 2023
52. MILBANK E, Dragano N, Vidal-Gomez X, Rivas-Limeres V, et al
    Small extracellular vesicle targeting of hypothalamic AMPKalpha1 promotes weight loss in leptin receptor deficient mice.
    Metabolism. 2023;139:155350.
    PubMed     Abstract available
    
    
    January 2023
53. BENEDICTE G, Sara F, Paul L, Laetitia N, et al
    Early humoral response to COVID-19 vaccination in patients living with obesity and diabetes in France. The COVPOP OBEDIAB study with results from the ANRS0001S COV-POPART cohort.
    Metabolism. 2023 Jan 30:155412. doi: 10.1016/j.metabol.2023.155412.
    PubMed     Abstract available
    
    
    
54. AHMED M, Makinen VP, Lumsden A, Boyle T, et al
    Metabolic profile predicts incident cancer: A large-scale population study in the UK Biobank.
    Metabolism. 2023;138:155342.
    PubMed     Abstract available
    
    
    
55. DISCHINGER U, Kotzner L, Kovatcheva-Datchary P, Kleinschmidt H, et al
    Hypothalamic integrity is necessary for sustained weight loss after bariatric surgery: A prospective, cross-sectional study.
    Metabolism. 2023;138:155341.
    PubMed     Abstract available
    
    
    December 2022
56. RAJAN S, Hofer P, Christiano A, Stevenson M, et al
    Microsomal triglyceride transfer protein regulates intracellular lipolysis in adipocytes independent of its lipid transfer activity.
    Metabolism. 2022;137:155331.
    PubMed     Abstract available
    
    
    
57. LARSSON SC, Spyrou N, Mantzoros CS
    Body fatness associations with cancer: evidence from recent epidemiological studies and future directions.
    Metabolism. 2022;137:155326.
    PubMed     Abstract available
    
    
    November 2022
58. XIE H, Wang YH, Liu X, Gao J, et al
    SUMOylation of ERp44 enhances Ero1alpha ER retention contributing to the pathogenesis of obesity and insulin resistance.
    Metabolism. 2022 Nov 22:155351. doi: 10.1016/j.metabol.2022.155351.
    PubMed     Abstract available
    
    
    
59. ANGELIDI AM, Kokkinos A, Sanoudou D, Connelly MA, et al
    Early metabolomic, lipid and lipoprotein changes in response to medical and surgical therapeutic approaches to obesity.
    Metabolism. 2022 Nov 11:155346. doi: 10.1016/j.metabol.2022.155346.
    PubMed     Abstract available
    
    
    
60. YANG HM, Kim J, Shin D, Kim JY, et al
    Resistin impairs mitochondrial homeostasis via cyclase-associated protein 1-mediated fission, leading to obesity-induced metabolic diseases.
    Metabolism. 2022;138:155343.
    PubMed     Abstract available
    
    
    
61. HEIANZA Y, Wang X, Rood J, Clish CB, et al
    Changes in circulating bile acid subtypes in response to weight-loss diets are associated with improvements in glycemic status and insulin resistance: The POUNDS Lost trial.
    Metabolism. 2022;136:155312.
    PubMed     Abstract available
    
    
    October 2022
62. DEMARSILIS A, Reddy N, Boutari C, Filippaios A, et al
    Pharmacotherapy of type 2 diabetes: An update and future directions.
    Metabolism. 2022 Oct 11:155332. doi: 10.1016/j.metabol.2022.155332.
    PubMed     Abstract available
    
    
    August 2022
63. CHAO Y, Gao L, Wang X, Cai Y, et al
    Dysregulated adipose tissue expansion and impaired adipogenesis in Prader-Willi syndrome children before obesity-onset.
    Metabolism. 2022 Aug 22:155295. doi: 10.1016/j.metabol.2022.155295.
    PubMed     Abstract available
    
    
    
64. FERNANDEZ-GARCIA JC, Barrios-Rodriguez R, Asenjo-Plaza M, Ramos-Molina B, et al
    Metformin, testosterone, or both in men with obesity and low testosterone: A double-blind, parallel-group, randomized controlled trial.
    Metabolism. 2022 Aug 16:155290. doi: 10.1016/j.metabol.2022.155290.
    PubMed     Abstract available
    
    
    
65. SHIN J, Toyoda S, Nishitani S, Onodera T, et al
    SARS-CoV-2 infection impairs the insulin/IGF signaling pathway in the lung, liver, adipose tissue, and pancreatic cells via IRF1.
    Metabolism. 2022;133:155236.
    PubMed     Abstract available
    
    
    July 2022
66. CHEN KW, Chen YS, Chen PJ, Yeh SH, et al
    Androgen receptor functions in pericentral hepatocytes to decrease gluconeogenesis and avoid hyperglycemia and obesity in male mice.
    Metabolism. 2022 Jul 29:155269. doi: 10.1016/j.metabol.2022.155269.
    PubMed     Abstract available
    
    
    June 2022
67. DU M, Li X, Xiao F, Fu Y, et al
    Serine active site containing protein 1 depletion alters lipid metabolism and protects against high fat diet-induced obesity in mice.
    Metabolism. 2022 Jun 24:155244. doi: 10.1016/j.metabol.2022.155244.
    PubMed     Abstract available
    
    
    
68. VALENZUELA-VALLEJO L, Chrysafi P, Bello-Ramos J, Bsata S, et al
    Circulating total and intact GDF-15 levels are not altered in response to weight loss induced by liraglutide or lorcaserin treatment in humans with obesity.
    Metabolism. 2022 Jun 11:155237. doi: 10.1016/j.metabol.2022.155237.
    PubMed     Abstract available
    
    
    May 2022
69. BOUTARI C, Mantzoros CS
    A 2022 update on the epidemiology of obesity and a call to action: as its twin COVID-19 pandemic appears to be receding, the obesity and dysmetabolism pandemic continues to rage on.
    Metabolism. 2022 May 15:155217. doi: 10.1016/j.metabol.2022.155217.
    PubMed     Abstract available
    
    
    
70. CAO C, Koh HE, Van Vliet S, Patterson BW, et al
    Increased plasma fatty acid clearance, not fatty acid concentration, is associated with muscle insulin resistance in people with obesity.
    Metabolism. 2022 May 13:155216. doi: 10.1016/j.metabol.2022.155216.
    PubMed     Abstract available
    
    
    
71. KIM YJ, Kim HJ, Lee SG, Kim DH, et al
    Aerobic exercise for eight weeks provides protective effects towards liver and cardiometabolic health and adipose tissue remodeling under metabolic stress for one week: A study in mice.
    Metabolism. 2022;130:155178.
    PubMed     Abstract available
    
    
    
72. SHE QY, Bao JF, Wang HZ, Liang H, et al
    Fibroblast growth factor 21: A "rheostat" for metabolic regulation?
    Metabolism. 2022;130:155166.
    PubMed     Abstract available
    
    
    
73. ZITTING KM, Vetrivelan R, Yuan RK, Vujovic N, et al
    Chronic circadian disruption on a high-fat diet impairs glucose tolerance.
    Metabolism. 2022;130:155158.
    PubMed     Abstract available
    
    
    April 2022
74. CHENG Y, Han J, Li Q, Shi Y, et al
    Metabolic obesity phenotypes: a friend or foe of digestive polyps?-An observational study based on National Inpatient Database.
    Metabolism. 2022 Apr 12:155201. doi: 10.1016/j.metabol.2022.155201.
    PubMed     Abstract available
    
    
    
75. UM JH, Park SY, Hur JH, Lee HY, et al
    Bone morphogenic protein 9 is a novel thermogenic hepatokine secreted in response to cold exposure.
    Metabolism. 2022;129:155139.
    PubMed     Abstract available
    
    
    March 2022
76. DU K, Sun L, Luo Z, Cao Y, et al
    Reduced DMPC and PMPC in lung surfactant promote SARS-CoV-2 infection in obesity.
    Metabolism. 2022 Mar 17:155181. doi: 10.1016/j.metabol.2022.155181.
    PubMed     Abstract available
    
    
    
77. FRUHBECK G, Becerril S, Martin M, Ramirez B, et al
    High plasma and lingual uroguanylin as potential contributors to changes in food preference after sleeve gastrectomy.
    Metabolism. 2022;128:155119.
    PubMed     Abstract available
    
    
    
78. KAPLANIAN M, Philippe C, Eid SA, Hackl MT, et al
    Deciphering metformin action in obese mice: A critical re-evaluation of established protocols.
    Metabolism. 2022;128:154956.
    PubMed     Abstract available
    
    
    February 2022
79. SON Y, Choi C, Saha A, Park JH, et al
    REEP6 knockout leads to defective beta-adrenergic signaling in adipocytes and promotes obesity-related metabolic dysfunction.
    Metabolism. 2022 Feb 9:155159. doi: 10.1016/j.metabol.2022.155159.
    PubMed     Abstract available
    
    
    January 2022
80. QU HQ, Qu J, Glessner J, Hakonarson H, et al
    Mendelian randomization study of obesity and type 2 diabetes in hospitalized COVID-19 patients.
    Metabolism. 2022 Jan 28:155156. doi: 10.1016/j.metabol.2022.155156.
    PubMed     Abstract available
    
    
    
81. PORFLITT-RODRIGUEZ M, Guzman-Arriagada V, Sandoval-Valderrama R, Tam CS, et al
    Effects of aerobic exercise on fibroblast growth factor 21 in overweight and obesity. A systematic review.
    Metabolism. 2022 Jan 14:155137. doi: 10.1016/j.metabol.2022.155137.
    PubMed     Abstract available
    
    
    
82. GONZALEZ-GARCIA I, Freire-Agulleiro O, Nakaya N, Ortega FJ, et al
    Olfactomedin 2 deficiency protects against diet-induced obesity.
    Metabolism. 2022 Jan 10:155122. doi: 10.1016/j.metabol.2021.155122.
    PubMed     Abstract available
    
    
    
83. SANOUDOU D, Hill MA, Belanger MJ, Arao K, et al
    Editorial: Obesity, metabolic phenotypes and COVID-19.
    Metabolism. 2022 Jan 10:155121. doi: 10.1016/j.metabol.2021.155121.
    PubMed    
    
    
    
84. LO T, Lee Y, Tseng CY, Hu Y, et al
    Daily transient coating of the intestine leads to weight loss and improved glucose tolerance.
    Metabolism. 2022;126:154917.
    PubMed     Abstract available
    
    
    
85. TAN EX, Lee JW, Jumat NH, Chan WK, et al
    Non-obese non-alcoholic fatty liver disease (NAFLD) in Asia: an international registry study.
    Metabolism. 2022;126:154911.
    PubMed     Abstract available
    
    
    December 2021
86. KAUR V, Dimitriadis GK, Perez-Pevida B, Bansi DS, et al
    Mechanisms of action of duodenal mucosal resurfacing in insulin resistant women with polycystic ovary syndrome.
    Metabolism. 2021;125:154908.
    PubMed     Abstract available
    
    
    November 2021
87. HJORTEBJERG R, Bojsen-Moller KN, Soeby M, Oxvig C, et al
    Metabolic improvement after gastric bypass correlates with changes in IGF-regulatory proteins stanniocalcin-2 and IGFBP-4.
    Metabolism. 2021;124:154886.
    PubMed     Abstract available
    
    
    September 2021
88. KOUVARI M, Chrysohoou C, Skoumas J, Pitsavos C, et al
    The presence of NAFLD influences the transition of metabolically healthy to metabolically unhealthy obesity and the ten-year cardiovascular disease risk: a population-based cohort study.
    Metabolism. 2021 Sep 30:154893. doi: 10.1016/j.metabol.2021.154893.
    PubMed     Abstract available
    
    
    
89. KIM NH, Kim KJ, Choi J, Kim SG, et al
    Metabolically unhealthy individuals, either with obesity or not, have a higher risk of critical coronavirus disease 2019 outcomes than metabolically healthy individuals without obesity.
    Metabolism. 2021 Sep 30:154894. doi: 10.1016/j.metabol.2021.154894.
    PubMed     Abstract available
    
    
    
90. PEI Z, Liu Y, Liu S, Jin W, et al
    FUNDC1 insufficiency sensitizes high fat diet intake-induced cardiac remodeling and contractile anomaly through ACSL4-mediated ferroptosis.
    Metabolism. 2021;122:154840.
    PubMed     Abstract available
    
    
    August 2021
91. ZHU Y, Kim SQ, Zhang Y, Liu Q, et al
    Pharmacological inhibition of acyl-coenzyme A:cholesterol acyltransferase alleviates obesity and insulin resistance in diet-induced obese mice by regulating food intake.
    Metabolism. 2021 Aug 6:154861. doi: 10.1016/j.metabol.2021.154861.
    PubMed     Abstract available
    
    
    
92. LANDRY T, Shookster D, Huang H
    Circulating alpha-klotho regulates metabolism via distinct central and peripheral mechanisms.
    Metabolism. 2021;121:154819.
    PubMed     Abstract available
    
    
    July 2021
93. VAN GALEN KA, Booij J, Schrantee A, Adriaanse SM, et al
    The response to prolonged fasting in hypothalamic serotonin transporter availability is blunted in obesity.
    Metabolism. 2021 Jul 28:154839. doi: 10.1016/j.metabol.2021.154839.
    PubMed     Abstract available
    
    
    June 2021
94. WANG Y, Xu J, Wang Y, Hou H, et al
    Obesity and COVID-19 mortality.
    Metabolism. 2021 Jun 22:154820. doi: 10.1016/j.metabol.2021.154820.
    PubMed    
    
    
    
95. CLEMENTE-OLIVO MP, Habibe JJ, Vos M, Ottenhoff R, et al
    Four-and-a-half LIM domain protein 2 (FHL2) deficiency protects mice from diet-induced obesity and high FHL2 expression marks human obesity.
    Metabolism. 2021 Jun 10:154815. doi: 10.1016/j.metabol.2021.154815.
    PubMed     Abstract available
    
    
    
96. PICHE ME, Clavel MA, Auclair A, Rodriguez-Flores M, et al
    Early benefits of bariatric surgery on subclinical cardiac function: Contribution of visceral fat mobilization.
    Metabolism. 2021;119:154773.
    PubMed     Abstract available
    
    
    
97. ZHANG Z, Lin T, Meng Y, Hu M, et al
    FOS/GOS attenuates high-fat diet induced bone loss via reversing microbiota dysbiosis, high intestinal permeability and systemic inflammation in mice.
    Metabolism. 2021;119:154767.
    PubMed     Abstract available
    
    
    May 2021
98. FREUER D, Linseisen J, Meisinger C
    Impact of body composition on COVID-19 susceptibility and severity: A two-sample multivariable Mendelian randomization study.
    Metabolism. 2021;118:154732.
    PubMed     Abstract available
    
    
    
99. HARRIS DA, Subramaniam R, Brenner T, Tavakkoli A, et al
    Weight and organ specific immune cell profiling of sleeve gastrectomy in mice.
    Metabolism. 2021;118:154729.
    PubMed     Abstract available
    
    
    April 2021
100. PIETRI L, Giorgi R, Begu A, Lojou M, et al
     Excess body weight is an independent risk factor for severe forms of COVID-19.
     Metabolism. 2021;117:154703.
     PubMed     Abstract available
     
     
     
101. DU Y, Lv Y, Zha W, Zhou N, et al
     Association of body mass index (BMI) with critical COVID-19 and in-hospital mortality: A dose-response meta-analysis.
     Metabolism. 2021;117:154373.
     PubMed     Abstract available
     
     
     
102. LIMA VM, Liu J, Brandao BB, Lino CA, et al
     miRNA-22 deletion limits white adipose expansion and activates brown fat to attenuate high-fat diet-induced fat mass accumulation.
     Metabolism. 2021;117:154723.
     PubMed     Abstract available
     
     
     February 2021
103. SANDHU B, Perez Matos MC, Tran S, Singhal G, et al
     Global deletion of NTPDase3 protects against diet-induced obesity by increasing basal energy metabolism.
     Metabolism. 2021 Feb 22:154731. doi: 10.1016/j.metabol.2021.154731.
     PubMed     Abstract available
     
     
     
104. CHEN SY, Beretta M, Alexopoulos SJ, Shah DP, et al
     Mitochondrial uncoupler SHC517 reverses obesity in mice without affecting food intake.
     Metabolism. 2021 Feb 3:154724. doi: 10.1016/j.metabol.2021.154724.
     PubMed     Abstract available
     
     
     
105. FAVRE G, Legueult K, Pradier C, Raffaelli C, et al
     Visceral fat is associated to the severity of COVID-19.
     Metabolism. 2021;115:154440.
     PubMed     Abstract available
     
     
     
106. NAKATSU Y, Yamamotoya T, Okumura M, Ishii T, et al
     Prolyl isomerase Pin1 interacts with adipose triglyceride lipase and negatively controls both its expression and lipolysis.
     Metabolism. 2021;115:154459.
     PubMed     Abstract available
     
     
     
107. PICHE ME, Tardif I, Auclair A, Poirier P, et al
     Effects of bariatric surgery on lipid-lipoprotein profile.
     Metabolism. 2021;115:154441.
     PubMed     Abstract available
     
     
     January 2021
108. ANGELIDI AM, Kokkinos A, Katechaki E, Ros E, et al
     Mediterranean diet as a nutritional approach for COVID-19.
     Metabolism. 2021;114:154407.
     PubMed    
     
     
     
109. LI K, Zhang K, Wang H, Wu Y, et al
     Hrd1-mediated ACLY ubiquitination alleviate NAFLD in db/db mice.
     Metabolism. 2021;114:154349.
     PubMed     Abstract available
     
     
     December 2020
110. WU Z, Xi P, Zhang Y, Wang H, et al
     LKB1 up-regulation inhibits hypothalamic inflammation and attenuates diet-induced obesity in mice.
     Metabolism. 2020 Dec 21:154694. doi: 10.1016/j.metabol.2020.154694.
     PubMed     Abstract available
     
     
     
111. LI L, Spranger L, Soll D, Beer F, et al
     Metabolic impact of weight loss induced reduction of adipose ACE-2 - Potential implication in COVID-19 infections?
     Metabolism. 2020;113:154401.
     PubMed     Abstract available
     
     
     
112. KIM MN, Lo CH, Corey KE, Liu PH, et al
     Weight gain during early adulthood, trajectory of body shape and the risk of nonalcoholic fatty liver disease: A prospective cohort study among women.
     Metabolism. 2020;113:154398.
     PubMed     Abstract available
     
     
     November 2020
113. ZENG Q, Wang L, Dong S, Zha X, et al
     CT-derived abdominal adiposity: distributions and better predictive ability than BMI in a nationwide study of 59,429 adults in China.
     Metabolism. 2020 Nov 28:154456. doi: 10.1016/j.metabol.2020.154456.
     PubMed     Abstract available
     
     
     
114. VOIGTMANN F, Wolf P, Landgraf K, Stein R, et al
     Identification of a novel leptin receptor (LEPR) variant and proof of functional relevance directing treatment decisions in patients with morbid obesity.
     Metabolism. 2020 Nov 19:154438. doi: 10.1016/j.metabol.2020.154438.
     PubMed     Abstract available
     
     
     
115. JI D, Zhang M, Qin E, Zhang L, et al
     Obesity, Diabetes, Non-alcoholic Fatty Liver Disease and Metabolic Dysfunction Associated Fatty Liver Disease are Proinflammatory Hypercoagulable States associated with Severe Disease and Thrombosis in Covid-19.
     Metabolism. 2020 Nov 18:154437. doi: 10.1016/j.metabol.2020.154437.
     PubMed    
     
     
     
116. RAPOSO HF, Forsythe P, Chausse B, Castelli JZ, et al
     Novel role of cholesteryl ester transfer protein (CETP): attenuation of adiposity by enhancing lipolysis and brown adipose tissue activity.
     Metabolism. 2020 Nov 6:154429. doi: 10.1016/j.metabol.2020.154429.
     PubMed     Abstract available
     
     
     October 2020
117. HILL MA, Sowers JR, Mantzoros CS
     Commentary: COVID-19 and Obesity Pandemics Converge into a Syndemic Requiring Urgent and Multidisciplinary Action.
     Metabolism. 2020 Oct 17:154408. doi: 10.1016/j.metabol.2020.154408.
     PubMed     Abstract available
     
     
     
118. DENT R, McPherson R, Harper ME
     Factors affecting weight loss variability in obesity.
     Metabolism. 2020 Oct 6:154388. doi: 10.1016/j.metabol.2020.154388.
     PubMed     Abstract available
     
     
     
119. WATANABE M, Caruso D, Tuccinardi D, Risi R, et al
     Visceral fat shows the strongest association with the need of intensive care in patients with COVID-19.
     Metabolism. 2020;111:154319.
     PubMed     Abstract available
     
     
     
120. MAJUMDAR A, Tsochatzis EA
     Changing trends of liver transplantation and mortality from non-alcoholic fatty liver disease.
     Metabolism. 2020;111S:154291.
     PubMed     Abstract available
     
     
     September 2020
121. HUANG Y, Yao LU, Huang YM, Wang M, et al
     Obesity in patients with COVID-19: a systematic review and meta-analysis.
     Metabolism. 2020 Sep 28:154378. doi: 10.1016/j.metabol.2020.154378.
     PubMed     Abstract available
     
     
     
122. MOIN ASM, Sathyapalan T, Atkin SL, Butler AE, et al
     M2 macrophage markers in type 2 diabetes.
     Metabolism. 2020 Sep 16:154374. doi: 10.1016/j.metabol.2020.154374.
     PubMed    
     
     

Thank you for your interest in scientific medicine.

AMEDEO Obesity is free of charge.